Anti-Cytokeratin 16/K16 antibody [EP1615Y]
Anti-Cytokeratin 16/K16 항체 [EP1615Y]
- RabMAb
- Recombinant
- 각 태그의 뜻
5
(2 리뷰들)
|
(23 제품이 사용된 논문 )
Rabbit Recombinant Monoclonal K1C16 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 23 publications.
대체 명칭 보기
KRT16A, KRT16, Cytokeratin-16, Keratin-16, CK-16, K16
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
ab76416 staining Cytokeratin 16/K16 in human skin tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/500. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control 1 : PBS in place of primary antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
Overlay histogram showing HepG2 cells stained with unpurified ab76416 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Triton for 20 min. The cells were then incubated in 1x PBS/10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76416, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Triton used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
ab76416 staining Cytokeratin 16/K16 in human skeletal muscle sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/500. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control 1 : PBS in place of primary antibody.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
ab76416 staining Cytokeratin 16/K16 in HACAT (human keratinocyte) cell lineby intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde and the sample was incubated with the primary antibody at a dilution of 1/150. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/500 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
ab76416 staining Cytokeratin 16/K16 in A431 (human epidermoid carcinoma) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody at a dilution of 1/100. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody. ab7291 and ab150120 were used as counterstains for primary antibody ab75748 and secondary antibody ab150077 respectively and DAPI was used as a nuclear counterstain.
Negative control 1 : Rabbit primary antibody and anti-mouse secondary antibody (ab150120)
Negative control 2 : Mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077)
- WB
Lab
Western blot - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
All lanes:
Western blot - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (ab76416) at 1/10000 dilution
All lanes:
HACAT (human keratinocyte) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a> at 1/20000 dilution
Predicted band size: 51 kDa
false
- ICC/IF
CiteAb
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 16/K16 antibody [EP1615Y] (AB76416)
Immunocytochemistry-immunofluorescence using Anti-Cytokeratin 16/K16 antibody [EP1615Y], ab76416. Publication image from Zhu, L. et al., 2022, Nat Commun, 35440136. Legend direct from paper.
Basal cytokeratins induction is independent of mutant ER genomic binding but requires low ER expression.a Heatmap representing fold change mRNA expression (E2/veh) of six basal cytokeratins and four luminal cytokeratins in ER+ breast cancer lines from six publicly available data sets (GSE89888, GSE94493, GSE108304, GSE3834, GSE38132, and GSE50693). GREB1, PGR, and TFF1 are canonical E2-regulated genes included as positive controls. b Genomic track showing ER binding intensities at KRT5/6A/6B and KRT14/16/17 loci from ER ChIP-seq data sets of MCF7 ESR1 mutant cells. GREB1 locus serve as a positive control. c Graphic view of Pearson correlation between expression of ESR1 and each basal or luminal cytokeratin in ER+ breast tumors in TCGA (n = 808) and METABRIC (n = 1505) cohorts. Color scale and size of dots represent correlation coefficient and significance, respectively. d qRT-PCR measurement of ESR1, KRT5/6A/6B/14/16/17 mRNA levels in MCF7 WT and ESR1 mutant cells with ESR1 siRNA knockdown for 7 days. mRNA fold changes were normalized to WT cells; RPLP0 levels were measured as internal control. Each bar represents mean ± SD with three biological replicates. Data shown are representative from three independent experiments. Student’s t-test (two-sided) was used to compare the gene expression between scramble and knockdown groups. e Representative images of ER, CK5, CK16, and CK17 staining in MCF7-Y537S and D538G cells. BCKs positive cells are highlighted with white arrows. Images were taken under x20 magnification. f Dot plots quantifying the ER intensities in BCKs positive (blue) and the corresponding proximal negative (red) cells from each region. Individual data points from five different regions per group from one experiment, representative of three independent experiments are shown. Paired t-test (two-sided) was applied to compare ER intensities between BCKs positive and negative cells. Source data are provided as a Source Data file for a, c, d, f.
관련 conjugated 항체와 다양한 조성의 항체 (4)
-
Anti-Cytokeratin 16/K16 antibody [EP1615Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytokeratin 16/K16 antibody [EP1615Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cytokeratin 16/K16 antibody [EP1615Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cytokeratin 16/K16 antibody [EP1615Y]
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
K16 plays critical roles in maintaining the integrity of epithelial cells and tissues. It is a structural protein that helps stabilize keratin cytoarchitecture. K16 forms a complex with its partner keratins like K17 providing resilience and elasticity to the skin ensuring durability in regions experiencing repetitive physical stress. Additionally K16 helps regulate proliferation and differentiation of keratinocytes contributing to healthy skin formation and repair.
Pathways
K16 takes part in signaling pathways associated with epidermal development and repair. It acts within the keratinization process interacting closely with signaling components that influence cell cycle regulation and DNA repair. Proteins such as p63 and Krt17 assist this regulatory mechanism influencing cellular responses to stress or damage. These interactions help modulate barrier function and skin homeostasis ensuring responsive adaptation to environmental changes.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (23)
Recent publications for all applications. Explore the 전체 목록 and refine your search
International journal of molecular sciences 24: PubMed37047109
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical medicine 12: PubMed36614907
2022
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 18:e1010775 PubMed35976902
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:2011 PubMed35440136
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:3122-3136 PubMed35037835
2022
Applications
Unspecified application
Species
Unspecified reactive species
Head & neck 44:177-188 PubMed34693597
2021
Applications
Unspecified application
Species
Unspecified reactive species
Dermatology (Basel, Switzerland) 238:236-243 PubMed34077928
2021
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 7: PubMed33571121
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 30:249-261 PubMed33067891
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 178:114048 PubMed32446889
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com